Skip to content

800.850.4306

  • About Us
    • Who We Are
    • Leadership
    • Accreditations
    • Careers
  • Insights
    • News
    • Our Stories
    • Events
  • Contact Us
  • About Us
    • Who We Are
    • Leadership
    • Accreditations
    • Careers
  • Insights
    • News
    • Our Stories
    • Events
  • Contact Us
  • Patients
    • Oncology
    • Rare and Orphan Care
    • Cell and Gene Therapy
    • Financial Assistance
    • Frequently Asked Questions
  • Providers
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Payers
  • How to Prescribe
    • Specialty Drugs List
  • Patients
    • Oncology
    • Rare and Orphan Care
    • Cell and Gene Therapy
    • Financial Assistance
    • Frequently Asked Questions
  • Providers
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Payers
  • How to Prescribe
    • Specialty Drugs List

Author: Sarah

ORGOVYX™ (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson

CARY, N.C., January 19, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

A Letter to Our Biopharma Clients About Organizational Changes

Valued Biopharma Partner, At Biologics by McKesson, we know that your complex, personalized therapies require customized support tailored to your […]

GAVRETO™ (pralsetinib), FDA Approved for Treatment of Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer, Available at Biologics by McKesson

CARY, N.C., September 17, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

INQOVI (cedazuridine and decitabine), FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson

CARY, N.C., August 21, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

Video Transcript: Optimizing Success for Community Physicians

Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL). Alison […]

Video Transcript: Oral Therapy Adverse Events

Key opinion leaders discuss which characteristics of oral therapies need to be managed by pharmacists. Alison Duffy, PharmD, BCOP: We talked […]

Video Transcript: Oral Oncolytics Versus Intravenous: Safety and Efficacy

A comparison of the safety and efficacy of orally and intravenously administered oncolytics. Alison Duffy, PharmD, BCOP: Dr Steeves, what has […]

Video Transcript: Developing Clinical Trials for Newly Diagnosed Disease

Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL). Alison Duffy, PharmD, BCOP: I’d […]

Video Transcript: Limited-Duration Therapy Based on MRD Testing

Experts in the field of chronic lymphocytic management (CLL) consider how MRD (minimum residual disease) testing affects the use of […]

A Letter to Our Customers from Our New General Manager, Brandon Tom

Valued Customers,  As the new vice president and general manager of Biologics by McKesson, let me start by saying I am truly thrilled to lead this wonderful […]

← Previous
Next →

11800 Weston Parkway
Cary, NC 27513
T. 800.850.4306

Legal

  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice
  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice

For Patients

  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)
  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)

Learn more about McKesson

  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe
  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe

© 2025 McKesson Corporation. All Rights Reserved.